Ms Mahreen Pakzad

Ms Mahreen PakzadTel: 020 3447 7080 (UCLH) / 020 3448 4713 (NHNN)

University College Hospital; National Hospital for Neurology and Neurosurgery

Uro-Neurology, Urology

Professional background

Mahreen Pakzad is a Consultant Urological Surgeon, trained at St. Bartholomew's Hospital Medical School in London. Her MD thesis was at UCL and is entitled "The role of adenosine in overactive bladder syndrome". She works in the department of Female, Functional and Restorative urology unit at UCLH providing anti-incontinence treatment and surgery, such as sacral neuromodulation and bladder wall BOTOX injections. Her role at The National Hospital of Neurology and Neurosurgery  is as a Consultant Urological Surgeon with a specialist interest in Uroneurology assessment and treatment of patients with bladder dysfunction as a result of neurological disease such as Multiple sclerosis and Parkinson's disease. She is particularly interested in the treatment of recurrent Urinary Tract Infection and works in close liaison with the Departments of Microbiology and Infectious Disease, providing a unique and multidisciplinary service.

Research interests

1. D-mannose in the treatment of recurrent UTI in patients with neurological disease.
2. An MRI study evaluating the CNS correlates in overactive bladder dysfunction.
3. The role off sacral neuromodulation in the treatment of men and women with high tone non-relaxing sphincter obstruction and consequences for the bladder.
4. The role of bespoke vaccines in the treatment of recurrent UTI in women.



1. Hussain M*, Hamid R, Arya M, Peters JL, Kellett MJ, Philp T.
Management of colonic injury following percutaneous nephrolithotomy. Int.J.Clin.Pract. 2003 Jul-Aug; 57(6):549 -50.

2. Hussain M*, Greenwell TJ, Shah PJR ,Mundy AR. BJUI 2004.
The long-term outcome of UroLume Wallstents in the treatment of recurrent urethral stricture disease BJUI. 2004 Nov; 94: 1037-1039.

3. Hussain M*, Venn SN, Greenwell TJ, Mundy AR. The current role of the artificial urinary sphincter for the treatment of urinary incontinence. J Urol. 2005 Aug;174(2):418-24. Review.

4. Fry CH, Hussain M*, McCarthy C, Ikeda Y, Sui G-P, Wu C.
Recent advances in detrusor muscle function. Scand J Urol Nephrol Suppl. 2004;(215):20-5.

5. Pakzad F, Hussain M*. Monkey See, Monkey Do. Ann R Coll Surg Eng (Sup)2005; 87: 25-26.

6. Wood DN, Allen SE, Hussain M*, Greenwell TJ, Shah PJRS.
Stomal complications of ileal conduits are significantly higher when formed in women with intractable urinary incontinence. J Urol. 2004 Dec;172(6 Pt 1):2300-3.

7. Hussain M*, Foley C. How Times Have Changed. BMJ. June 2006.332:1488.

8. Blake-James B.T., Hussain M*, Peters JL. Genital foreign bodies:More than the eye can see. European Journal of Emergency Medicine.2007;14:53-55.

9. Hussain M*, Webster G. Should laparoscopic Millin’s prostatectomy become the new Gold Standard for large benign prostates?  Annals of The Royal College of Surgeons of Edinburgh, May 2006.

10. Hussain M*, Nethercliffe J. Update on the non-medical management of the overactive bladder. Urology News. July 2004.

11. Hussain M*, Woodhouse CRJ, Thompson A.
The value of ureteric stenting in the management of malignant ureteric obstruction. European Urology Supplements 2 (2003) No.1;200.

12. Hussain M*, Greenwell TJ, Shah PJR ,Milroy E, Mundy AR.
The long-term outcome of UroLume Wallstents in the treatment of recurrent urethral stricture disease. European Urology Supplements 2 (2003) No.1;149.

Section 4: Cell Biology of The Lower Urinary Tract. Sub-section: Biomechanics of the bladder. Brading A, Fowler C, Fry CH, Hussain M*,Uvelius B. In Incontinence. Editors: P Abrams, Khoury S, Wein A. 2004.  3rd Edition.

Hussain M* Greenwell TJ. Urethral Stricture Disease. Pg. 740-2. Conns Current Therapy. Saunders Elsevier 2009. Edited by Robert E. Rakel & Edward T. Bope.

GMC/GDC number: 4412744